PTC Therapeutics to Participate at Upcoming Investor Conference on September 27 2018
Published: Sep 13, 2018
SOUTH PLAINFIELD, N.J., Sept. 13, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at Jefferies Gene Therapy Summit on Thursday, September 27th at 1:30 p.m. EST.
The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 2 weeks following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. PTC's current Investor Presentation is available at the same website location.
About PTC Therapeutics, Inc.
PTC is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Founded 20 years ago, PTC Therapeutics has successfully launched two rare disorder products and has a global commercial footprint. This success is the foundation that drives investment in a robust pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.
FOR MORE INFORMATION PLEASE CONTACT: Media: Investors: Jane Baj Emily Hill +1 (908) 912-9167 +1 (908) 912-9327 email@example.com firstname.lastname@example.org
SOURCE PTC Therapeutics, Inc.
Company Codes: NASDAQ-NMS:PTCT